Jose Ochoa is Chief Business Officer at Altimmune.
José has served as chief business officer to Altimmune since July of 2018. He has more than two decades of experience structuring, negotiating and completing complex and accretive transactions including joint ventures, partnerships, mergers, acquisitions, debt financings, licensing and restructurings in a broad range of industries.
Prior to joining Altimmune, he served as chief business officer and head of animal health Americas at IDT Biologika Corporation. José worked at Emergent BioSolutions and its predecessor BioPort Corporation for over a decade, prior to IDT, where he held several positions of increasing responsibility. José served as general counsel at BioPort, East West Resources Corporation, BellSouth International (now AT&T), Luce Forward Hamilton & Scripps and Arent Fox.
He earned his juris doctor and bachelor of arts, with distinction, from the University of Virginia.